Bringing Indian Medicines to the US: What FDA Allows

FDA lets foreign nationals carry about a 90-day supply of personal medicines, but it treats Indian generics as unapproved and admits them only by discretion. See the DEA rules for tramadol, alprazolam and codeine syrups, and the heavy-metal alerts on Ayurvedic products.

FDA Quantity Guide
90-day supply
DEA Travel Rule
21 CFR 1301.26
U.S. Resident Cap
50 dosage units
Key Policy
FDA RPM 9-2

Bringing medicines from India to the United States is not a right under U.S. law, but FDA usually lets small personal quantities through. For a traveler who is not a U.S. citizen or permanent resident, the working rule is a supply of up to 90 days, carried in the original pharmacy packaging with a prescription or doctor’s letter in English. U.S. citizens and green card holders face a stricter rule.

The catch most Indian travelers miss is that FDA treats an Indian-made generic as an unapproved drug even when the same molecule is sold in the U.S. under an FDA-approved label. CBP states that foreign-made versions of U.S.-approved drugs “haven’t been evaluated or approved by the FDA.” They are admitted, when they are admitted, because FDA chooses not to enforce the ban against small personal quantities. That is enforcement discretion, not permission.

This guide covers students arriving on F-1 visas, parents on B-1/B-2 visas, H-1B workers and new green card holders who want to carry or receive a refill of their regular medicines. It explains the FDA personal importation policy in plain terms, what changes when you carry versus mail, which common drugs are controlled substances in the U.S., and where Ayurvedic and herbal products run into import alerts.

Controlled substances are the real danger zone. A drug that is routine at an Indian pharmacy, such as tramadol, alprazolam or a codeine cough syrup, sits on a U.S. DEA schedule, and a separate federal rule governs how you may carry it. A mistake there can mean seizure of the medicine or a criminal referral, not just a returned parcel.

This is import-rule information only. It does not tell you what to take or whether a substitute is safe. Ask your doctor about continuity of treatment before you travel, and ask a U.S. doctor to write a new prescription if you will be staying long.

For the general rules on any prescription medicine, see our companion guide on bringing prescription medications into the U.S. for personal use. This article applies those rules to medicines bought in India.

1

Find out which rule applies to you

FDA defines a foreign national as “any person who is not a citizen or permanent resident of the U.S.” That split decides how much you can carry.

FDA says it “will allow foreign nationals to bring or ship a 90-day supply of drug products.” CBP’s guidance for visitors says the same: carry a valid prescription or doctor’s note written in English, keep the medicine in its original container with the doctor’s instructions on the label, and bring no more than a 90-day supply. If you stay longer than 90 days, FDA says you “may have additional medication sent” to you.

U.S. citizens are in a different position. CBP says “in most cases, it’s illegal for a U.S. citizen to obtain drugs from outside the U.S. and import for personal use.” FDA’s definition of a foreign national leaves out permanent residents, so green card holders fall on the same side as citizens. FDA lists limited circumstances where it may exercise discretion, which are set out in Step 2.

Which rule applies to you
Foreign national (visitor, student, worker)U.S. citizen or permanent resident
FDA quantity guideUp to 90-day supplyGenerally not more than a three-month supply, and only inside FDA’s criteria
Starting pointCarry the medicine with your prescription or doctor’s letterImporting for personal use is illegal in most cases; FDA may use discretion
Longer stayHave more sent by mail or courierGet a U.S. prescription
Controlled drugsDEA rule 21 CFR 1301.26 appliesSame rule, plus a 50 dosage unit cap for U.S. residents
2

Understand the FDA personal importation policy

The policy sits in FDA’s Regulatory Procedures Manual, chapter 9, section 9-2-5 (March 2024 version). It opens with a warning that cuts against many travelers’ assumptions: FDA may use discretion to admit violative items, but “this should not be interpreted as a license to individuals to bring in such shipments.”

Under that section FDA staff may take a more permissive view in two situations. The first is when the product is not for a serious condition and is not known to be a significant health risk. The second is when all of the following hold for a drug that is unapproved in the U.S.:

FDA criteria for the serious-condition exception
  • The intended use is for a serious condition for which effective treatment may not be available domestically, through commercial or clinical means.
  • There is no known commercialization or promotion of the product to people living in the U.S. by those distributing it.
  • The product is considered not to represent an unreasonable risk.
  • The importer affirms in writing that it is for the patient’s own use, generally not more than a 3-month supply.
  • The importer gives the name and address of the U.S.-licensed doctor responsible for treatment, or evidence that the product continues a treatment begun abroad.

Two points follow for Indian medicines. First, a generic of a drug that has a U.S. approved version rarely fits the “treatment not available domestically” language, because the U.S. version exists. Whether it passes at the airport depends on an officer and on FDA’s case-by-case discretion, which is why the paperwork and the small quantity matter. Second, the manual says drugs subject to an FDA import alert “are not amenable to these procedures,” so a flagged product gets no discretion at all.

The manual also treats a supply that “exceeds what one person might take in approximately three months” as a sign of commercial distribution, and commercial shipments are outside the personal-use procedures. That is why a six-month stockpile in a suitcase invites a seizure even if every bottle is labeled correctly.

FDA: Personal Importation
The agency’s plain-language policy page
Warning

An Indian generic is not “approved” just because it is the same molecule. FDA’s page says that if a drug is approved in another country but is an unapproved new drug in the U.S., it is illegal to import. Small personal quantities get through on discretion, and an officer can still refuse them.

3

Carry it in your luggage the right way

Luggage is the easier route. The manual says FDA staff do not examine personal baggage; that job belongs to CBP, which refers a case to FDA only if it sees something intended for commercial distribution, something FDA has asked it to hold, or something that looks like a health fraud or unknown risk. A traveler with a small, labeled supply rarely gets that far.

Pack so that an officer can see in seconds that the medicine is yours and ordinary:

Carry-on checklist for medicines
  • Original pharmacy or manufacturer packaging, with the label and the doctor’s instructions visible
  • A prescription or doctor’s letter in English that names the drug by its generic name and the dose
  • No more than a 90-day supply if you are a foreign national
  • Medicines in your carry-on, not checked bags, so you have them if the checked bag is delayed
  • The generic name written out for any Indian brand name, since officers may not know the brand
  • Answers ready on why you need the quantity and how long you are staying

CBP’s guidance does not list medicines as a standard declaration item on its prohibited and restricted page, but you must answer officer questions truthfully, and the DEA rule in Step 4 requires a spoken declaration for controlled drugs. If you carry anything beyond ordinary personal medicines, say so. A truthful declaration costs you a few minutes in secondary inspection; a false answer turns a paperwork issue into a bigger problem.

Parents arriving on visitor visas are often questioned at secondary inspection about the purpose of the trip, and a bag of medicines is part of that conversation. Our guide on secondary inspection questions for Indian parents visiting the USA covers what officers ask.

4

Check whether any of your medicines are controlled in the U.S.

A controlled substance is a drug on a DEA schedule. CBP says that if your medicine is a controlled substance, “you will also need to comply with the requirements of the Drug Enforcement Administration (DEA).”

The DEA’s travel exemption is 21 CFR 1301.26. It covers an individual carrying a Schedule II, III, IV or V controlled substance obtained lawfully for personal medical use. The conditions are:

Conditions under 21 CFR 1301.26
  • The substance stays in the original container in which it was dispensed to you
  • You declare to the customs officer that it is for your own use (or for an animal traveling with you)
  • You state the drug’s trade or chemical name and schedule symbol if they appear on the label; if they do not, you give the name and address of the dispensing pharmacy or practitioner and the prescription number
  • If you are a U.S. resident, no more than 50 dosage units combined of controlled substances obtained abroad

Residency here means your principal, actual dwelling place, regardless of intent. A student who lives in U.S. housing and returns from a summer in India may count as a U.S. resident for this purpose, so the 50 unit cap can apply to a returning F-1 student. If you are unsure, assume it applies. The 50 unit limit does not apply to controlled substances lawfully obtained in the United States on a U.S. prescription.

Here are common medicines that Indian travelers carry and the federal schedule each one holds, per the DEA’s list of controlled substances (checked November 6, 2026):

Common drugs and their U.S. schedule
DrugU.S. federal scheduleWhat to do
TramadolSchedule IVControlled; 1301.26 conditions apply
AlprazolamSchedule IVControlled; 1301.26 conditions apply
Diazepam, clonazepam, lorazepamSchedule IVControlled; 1301.26 conditions apply
ZolpidemSchedule IVControlled; 1301.26 conditions apply
Modafinil, carisoprodolSchedule IVControlled; 1301.26 conditions apply
PregabalinSchedule VControlled; 1301.26 conditions apply
Codeine cough preparations (up to 200 mg per 100 ml)Schedule VControlled; check the label for codeine content
Codeine combination tablets (up to 90 mg per dosage unit)Schedule IIIControlled; 1301.26 conditions apply
Codeine alone, oxycodoneSchedule IIControlled; plan for strict scrutiny

The schedule depends on the exact formulation and strength. Read the active ingredients on the strip, not just the brand name, and look up the generic name on the DEA’s current schedule list. Gabapentin does not appear on the DEA’s federal schedule list, but a drug’s absence from the list does not make it approved in the U.S., so it still falls under the FDA rules in Step 2.

Warning

Do not treat easy availability at an Indian pharmacy as a sign that a drug is legal to bring. A controlled substance in checked luggage without the original container and a declaration puts you outside 21 CFR 1301.26. Do not mail controlled substances to yourself.

DEA Diversion Control: Controlled Substance Schedules
Look up the schedule for any drug by generic name
5

Mailing or couriering medicines is riskier than carrying them

A parcel does not have a person standing next to it to explain. Under FDA’s manual, mail arriving at an International Mail Facility is examined by a CBP officer from the CBP Mail Division, who sets aside any parcel that appears to contain a drug, biologic or device. FDA then audits those parcels, and the shipment is held by CBP until it is either released or refused entry.

FDA says that if you are having medication sent by mail or courier, you should include documentation showing the medicine is for your own use while visiting the U.S., such as a copy of your visa or passport, a doctor’s letter, and a copy of the prescription in English. FDA lists “Shipment appears to be intended for commercial distribution” among the reasons it may refuse a shipment.

The manual adds that drugs valued at $2,500 or less that are refused admission, or that fail the personal importation criteria, are subject to destruction by FDA. Drugs under DEA jurisdiction go back to CBP for handling instead.

Do not order from online sellers that ship without a prescription. FDA’s policy criteria include “no known commercialization or promotion of the product to persons residing in the U.S.” A seller that markets to U.S. buyers is exactly the case the policy treats as a commercial or promotional shipment. For a general look at what happens to parcels at U.S. customs, see our case study on UPS customs clearance from India to the USA.

Tip

If you will be in the U.S. for more than a few months, the cleaner solution is a U.S. prescription filled at a U.S. pharmacy. That avoids the unapproved-drug question entirely.

6

Be careful with Ayurvedic and herbal products

FDA’s position on Ayurvedic products is blunt: “There are no FDA-approved ayurvedic products,” and those sold to prevent, treat, diagnose or cure disease are illegally marketed in the U.S. (FDA page current as of December 2, 2025).

The agency also warns that unapproved Ayurvedic products can cause heavy metal poisoning, with symptoms such as high blood pressure, kidney injury and neurologic effects, and that they “typically are not labeled to contain heavy metals such as lead, mercury or arsenic.” Its testing of one product, Rheumacare, found high levels of lead and mercury, plus strychnine, brucine and arsenic.

At the border this plays out through import alerts. FDA Import Alert 99-42, which covers foods held without physical examination because of heavy metal contamination, lists several Indian Ayurvedic firms, including Baidyanath-brand products dated April 1, 2021, and notes FDA’s conclusion that consuming any one of 10 listed Ayurvedic dietary supplements would likely be injurious to health from mercury, lead or both. Because the manual says goods under an import alert are generally outside the personal-use procedures, a listed product has no discretion to rely on.

In practice, treat packaged Ayurvedic medicines the way you treat other unapproved drugs: small quantity, original packaging, a clear ingredient list, and no expectation that an officer will let them in. Loose powders, unlabeled mixtures and anything from a roadside or door-to-door seller are the worst candidates. Simple culinary spices and teas are a food-import question rather than a medicine one, and our guide on what you cannot bring into the US covers food and agricultural limits.

FDA warning on Ayurvedic products
Heavy metal poisoning and unapproved products
7

Use the what-you-can-bring table

This table pulls the rules above into one view. “Risk” is VisaVerge’s reading of how likely the item is to cause trouble, not an official rating.

What you can bring: item, rule, risk
ItemRuleRisk
Indian generic of a common prescription drug (non-controlled), foreign nationalUp to 90-day supply, original packaging, English prescription or letterLow if labeled and small
Same drug, U.S. citizen or permanent residentImporting for personal use is illegal in most cases; FDA discretion onlyMedium
Over-the-counter pain, cold or stomach remediesFDA drug rules still apply; keep packaged, small quantityLow
Tramadol, benzodiazepines, zolpidem, modafinil, pregabalinSchedule IV or V; 21 CFR 1301.26 original container and declarationHigh
Codeine cough syrup or tabletsSchedule II, III or V depending on formulation; DEA rule appliesHigh
More than 90 days of any drugLooks like commercial quantityHigh
Packaged Ayurvedic medicineNo FDA-approved Ayurvedic products; import alerts for heavy metalsMedium to high
Loose or unlabeled herbal powdersNo label, no ingredient check; likely detainedHigh
Medicine mailed or couriered to yourselfCBP mail review, possible FDA refusal; documentation advisedMedium to high
Medicine for relatives or friendsNot for your own use; outside the personal-use policyHigh

Common mistakes

1
Assuming an Indian generic is the same as the approved version

FDA treats a foreign-made version of a U.S.-approved drug as unapproved. Carry it as a small personal supply and expect that an officer has the discretion to refuse.

2
Taking the medicine out of its packaging

Loose strips in a zip bag or a single mixed bottle break the original-container rule that both CBP and 21 CFR 1301.26 rely on.

3
Skipping the declaration on a controlled drug

The DEA exemption depends on a declaration to the customs officer. Staying silent can take you outside it.

4
Carrying medicine for relatives in the U.S.

The personal-use policy covers the patient’s own use. A bag of refills for an aunt or a friend looks like distribution.

5
Mailing controlled drugs or large supplies

Parcels are reviewed without you present. DEA drugs go back to CBP, and refused drugs of $2,500 or less may be destroyed by FDA.

After you arrive

If you plan to stay, set up a U.S. prescription early. Visitors without U.S. coverage should also read our piece on B1/B2 visitor health insurance, because a visitor without coverage pays for any U.S. care and medicine out of pocket. For the entry form itself, see our guide to the customs declaration form 6059B. If CBP detains your medicine or sends you to secondary inspection, stay calm, answer only what you are asked, and keep the prescription and letter handy. This guide is general information, not legal or medical advice, and agency rules change, so confirm the current wording on the FDA, CBP and DEA pages before you travel.

Frequently Asked Questions

Can I bring Indian medicines to the US in my luggage?

Foreign nationals may bring up to a 90-day supply, according to FDA and CBP, in original packaging with a prescription or doctor’s letter in English. It is enforcement discretion, not a right, so an officer can still refuse the medicine.

Is an Indian generic drug legal in the US?

FDA treats a foreign-made version of a U.S.-approved drug as unapproved, and CBP says such drugs have not been evaluated by FDA. Small personal quantities are usually let through at FDA’s discretion, but that is not formal approval.

How many days of medicine can I bring from India?

FDA allows foreign nationals a 90-day supply of drug products. For U.S. citizens, FDA’s guidance is generally not more than a three-month supply, and only inside its criteria. A larger amount can look like commercial distribution.

Can a US citizen bring medicine from India for personal use?

CBP says in most cases it is illegal for a U.S. citizen to obtain drugs abroad and import them for personal use. FDA may use discretion if its criteria are met, including a written personal-use statement and a three-month limit.

Is tramadol or alprazolam allowed in the US?

Both are Schedule IV controlled substances under DEA rules. Under 21 CFR 1301.26 you may carry a personal supply in its original container if you declare it to the customs officer, and U.S. residents are capped at 50 dosage units.

Can I mail medicine from India to the US?

You can, but mail goes through CBP review and possible FDA action, and may be refused. FDA advises including your visa or passport copy, a doctor’s letter and an English prescription. Controlled drugs are returned to CBP for handling.

Are Ayurvedic medicines allowed into the US?

FDA says there are no FDA-approved Ayurvedic products, and it has warned about lead, mercury and arsenic in unapproved ones. Products on a heavy-metal import alert such as 99-42 get no discretion at the border.

Do I have to declare medicines to CBP?

CBP’s medication guidance tells travelers to follow FDA rules but lists no general declaration step. For controlled substances, 21 CFR 1301.26 requires you to declare them to the customs officer. Answer all officer questions truthfully.

Keep reading

More in Guides →
What do you think? 52 reactions
Useful? 100%
Subscribe
Notify of
guest

0 Comments
Shashank Singh

Shashank Singh reports on India and South Asia immigration for VisaVerge.com, with a strong focus on international students and the Indian diaspora — from F-1 study routes and student safety to news affecting Indians abroad and in the Gulf. He delivers timely, accurate coverage and presents complex developments in an accessible way. Shashank keeps VisaVerge's large South Asian readership at the forefront of the news that matters to them.